(Q39274912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

review article

1 reference

title

Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Ammad Ahmad Farooqi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Andrea Papadia

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Assunta Casorelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Erlisa Bardhi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Aris Raad Besharat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Delia Savone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Ilary Ruscito

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Michael David Mueller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Elisabetta Ferretti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Pierluigi Benedetti Panici

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

1 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

1010428317695525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Immunologic systemic effect of neoadjuvant chemotherapy requires investigation before tumor-associated lymphocytes can be introduced in breast cancer treatment algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Past, present and future strategies of immunotherapy in gynecological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Laparoscopic pelvic and paraaortic lymphadenectomy in gynecologic oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Olaparib, PARP1 inhibitor in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Monoclonal antibodies in gynecological cancer: a critical point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Monoclonal antibodies therapies for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Cediranib in ovarian cancer: state of the art and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Cancer treatment and survivorship statistics, 2016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Circulating microRNAs as novel minimally invasive biomarkers for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Is miR-34a a Well-equipped Swordsman to Conquer Temple of Molecular Oncology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

miRBase: annotating high confidence microRNAs using deep sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Identification of hundreds of conserved and nonconserved human microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Recent updates on the role of microRNAs in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Role of anti-oncomirs miR-143 and -145 in human colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Diverse functions of miR-125 family in different cell contexts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

High-throughput microRNA profiling of pediatric high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

The role of microRNA-200 in progression of human colorectal and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

The microRNA spectrum in 12 body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Methodological challenges in utilizing miRNAs as circulating biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

A translational study of urine miRNAs in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Requirement of bic/microRNA-155 for normal immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Regulation of the germinal center response by microRNA-155

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

miR-155: on the crosstalk between inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Urinary microRNA profiling in the nephropathy of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MicroRNAs in acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Profiling of serum and urinary microRNAs in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Feasibility of urinary microRNA profiling detection in intrahepatic cholestasis of pregnancy and its potential as a non-invasive biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Circulating microRNAs, potential biomarkers for drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Micro-RNA-122 levels in acute liver failure and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Circulating microRNAs in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Changes in circulating microRNA levels associated with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Identification of cell-free microRNAs in the urine of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Vitamin D and miRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Human epididymis protein 4 expression positively correlated with miR-21 and served as a prognostic indicator in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

miRNA dysregulation in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Tumour angiogenesis regulation by the miR-200 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

BRCA1 and microRNAs: emerging networks and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Circulating microRNAs in breast cancer and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Aberrant expression of miR-638 contributes to benzo(a)pyrene-induced human cell transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Novel genetic variants in microRNA genes and familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

Detection and Characterization of Placental MicroRNAs in Maternal Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695525

21 January 2018

Identifiers

DOI

10.1177/1010428317695525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28459207%20AND%20SRC:MED&resulttype=core&format=json

release_zlimp5qvefcj3hotcasduldpsu

19 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zlimp5qvefcj3hotcasduldpsu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference